Additionally, the repeated demonstration of identical TNNI3 mutations manifesting as either HCM or RCM suggests the presence of unknown influencing factors, such as modifier genes or epigenetic influences, highlighting the challenge of predicting clinical manifestation and subsequent treatments based on mutation profile alone. Here, TNNI3 is linked to cardiomyopathy, familial restrictive, 1.